iPath Inverse S&P 500 VIX Short-Term Futures
IVOP
IVOP was delisted on the 23rd of March, 2018.
4 hedge funds and large institutions have $1.84M invested in iPath Inverse S&P 500 VIX Short-Term Futures in 2013 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $668K | +$672K | +18,075 | New |
|
2
Barclays
London,
United Kingdom
| $602K | +$606K | +16,291 | New |
|
|
FTUS
3
Flow Traders U.S.
New York
| $522K | +$526K | +14,146 | New |
|
|
U
4
UBS
Zurich,
Switzerland
| $47K | +$47.8K | +1,286 | New |
|
IVOP Hedge Fund Activity: Q2 2013 in Review
4 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) for Q2 2013, worth a combined $1.84M.
Buyers outnumbered sellers: 4 funds opened new IVOP positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
- 4 institutional investors held iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.84M of iPath Inverse S&P 500 VIX Short-Term Futures stock for Q2 2013.
- 4 funds opened new iPath Inverse S&P 500 VIX Short-Term Futures positions in Q2 2013 and 0 closed out, a net change of +4 holders.
Based on aggregated 13F filings for Q2 2013.